Stock Analysis

Exelon Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line

NasdaqGS:EXC
Source: Shutterstock

Exelon (NASDAQ:EXC) Full Year 2024 Results

Key Financial Results

  • Revenue: US$23.0b (up 6.0% from FY 2023).
  • Net income: US$2.46b (up 5.7% from FY 2023).
  • Profit margin: 11% (in line with FY 2023).
  • EPS: US$2.45 (up from US$2.34 in FY 2023).
revenue-and-expenses-breakdown
NasdaqGS:EXC Revenue and Expenses Breakdown February 14th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Exelon Revenues Beat Expectations

Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) was mostly in line with analyst estimates.

The primary driver behind last 12 months revenue was the Commonwealth Edison Company (ComEd) segment contributing a total revenue of US$8.22b (36% of total revenue). Notably, cost of sales worth US$13.6b amounted to 59% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Depreciation & Amortisation (D&A) costs, amounting to US$3.59b (52% of total expenses). Explore how EXC's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Electric Utilities industry in the US.

Performance of the American Electric Utilities industry.

The company's shares are up 4.0% from a week ago.

Risk Analysis

Before you take the next step you should know about the 2 warning signs for Exelon (1 is significant!) that we have uncovered.

Valuation is complex, but we're here to simplify it.

Discover if Exelon might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGS:EXC

Exelon

A utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada.

Good value with acceptable track record.

Community Narratives

AstraZeneca's Oncology and Obesity Innovations Will Drive Revenue Growth by 10%
Fair Value SEK 2.55k|36.403% undervalued
Unike
Unike
Community Contributor
Leading the Charge in SME SaaS Innovation
Fair Value SEK 100.02|25.014999999999997% undervalued
Investingwilly
Investingwilly
Community Contributor
Brookfield Corporation is a solid BUY for a long-term portfolio
Fair Value CA$82.23|4.1226% overvalued
Jonataninho
Jonataninho
Community Contributor